Hong Wen, PhD

Livzon Pharmaceutical Group

Chief Scientific Officer

Dr. Hong Wen, a former scientific lead and senior reviewer of US FDA, joined Livzon Pharmaceutical Group as Chief Scientific Officer in 2018.  Since joined FDA in 2013, his responsibilities covered guidance development, complex drug product review and post-marketing investigation.  His research focused on the impact of drug delivery on therapeutic performance of drug products.  Prior to joining FDA, Hong has worked 11 years in pharmaceutical industry and has contributed to multiple IND/IMPD/NDA filings including nine NDA approvals. During his tenure in Novartis, he was project leader of multiple development teams and a core member of Novartis TRD Science & Technology committee, as well as a recipient of Novartis’ highest scientific honor, “Novartis Leading Scientist”.  Dr. Wen graduated from the Department of Chemistry, Fudan University in 1987, and obtained his Ph.D. in Industrial and Physical Pharmacy from Purdue University in 2002.